Q:

A new marker that has possible utility in the management of patients with non–small-cell lung cancer (NSCLC) is:

0

A new marker that has possible utility in the management of patients with non–small-cell lung cancer (NSCLC) is:


  1. Calcitonin
  2. Neuron-specific enolase.
  3. CYFRA 21-1.
  4. Glucagon
  5. Chromogranin A.

All Answers

need an explanation for this answer? contact us directly to get an explanation for this answer

C. CYFRA 21-1.

DISCUSSION: CYFRA 21-1 is a new marker for non–small-cell lung cancer (NSCLC). Approximately 40% to 50% of patients with NSCLC will have elevated levels.

need an explanation for this answer? contact us directly to get an explanation for this answer

total answers (1)

Similar questions


need a help?


find thousands of online teachers now